New Jersey Assembly Bill A1679

New Jersey 2024-2025 Regular Session

• Introduced: 1/9/24
• Refer: 1/9/24
• Refer: 5/20/24

Caption

Requires health insurers, SHBP, and SEHBP to cover mammograms for women over 35 and women under 35 under certain circumstances.

Impact

The implications of A1679 are significant, as it broadens the accessibility of critical health services to a younger demographic of women. By lowering the age for mandatory coverage, the bill promotes proactive health screenings, which are essential for early diagnosis and treatment of breast cancer. This could potentially lead to lower healthcare costs in the long run, as early detection often results in less aggressive treatments and better survival rates. Insurance providers will need to adjust their policies accordingly to comply with the new requirements, which may lead to discussions about the cost implications of extending coverage to a younger patient base.

Summary

Assembly Bill A1679, introduced in the New Jersey Legislature, seeks to amend health insurance coverage policies related to mammograms. Specifically, the bill mandates that health insurers and health benefits plans cover mammogram examinations for women starting at age 35, reversing the current stipulation that coverage begins at age 40. This change aims to enhance early detection of breast cancer, an initiative supported by various health advocates and organizations due to the potential for improved health outcomes. Furthermore, the bill stipulates additional coverage for women under the age of 35 who have a family history of breast cancer or other risk factors, allowing them to receive screenings based on medical necessity as determined by their healthcare providers.

Contention

While the bill is largely supported by healthcare advocates who emphasize the importance of early detection, there may be contention regarding the financial impact on health insurers and how this might reflect in policy costs for consumers. Opponents could argue that reducing the age for coverage might lead to increased premiums or additional costs passed onto consumers. Furthermore, there may be debates surrounding the effectiveness of early mammograms for women aged 35 to 39, as this demographic has traditionally been at a lower risk for breast cancer. These discussions could shape the legislative journey of A1679 as it makes its way through policy reviews and votes.